Latest Shareholder Interests News

Page 20 of 40
Coda Minerals has announced a fully underwritten $8.33 million entitlement offer to fund the pre-feasibility study of its Elizabeth Creek Copper-Silver Project, offering shareholders a discounted entry price with attaching options.
Maxwell Dee
Maxwell Dee
8 Sept 2025
Verity Resources has successfully raised $3 million through a two-tranche placement to accelerate drilling and resource upgrades at its Monument Gold Project amid strong gold market conditions.
Maxwell Dee
Maxwell Dee
4 Sept 2025
Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.
Sophie Babbage
Sophie Babbage
4 Sept 2025
Tasmea Limited has firmly denied recent media speculation about potential block trades by its executive directors, reaffirming their strong shareholding and commitment to growth. The company is focused on organic expansion and acquisitions to secure ASX 300 inclusion next year without raising new capital.
Victor Sage
Victor Sage
3 Sept 2025
Charger Metals NL has appointed mining veteran Bryan Dixon as CEO, signaling a strategic shift to boost exploration and shareholder value at its lithium and gold projects.
Maxwell Dee
Maxwell Dee
3 Sept 2025
Lincoln Minerals Limited has announced a supplementary prospectus to raise an additional $750,000 through a Follow-on Placement, responding to strong investor demand beyond its initial entitlement offer.
Maxwell Dee
Maxwell Dee
3 Sept 2025
Washington H. Soul Pattinson and Brickworks Limited are advancing their proposed merger with key shareholder meetings and Supreme Court hearings scheduled in September 2025.
Victor Sage
Victor Sage
2 Sept 2025
4DS Memory Limited posted a $9.68 million loss for FY2025 as it advanced its 20nm ReRAM technology, encountering manufacturing setbacks that prompted a detailed root cause analysis. The company secured $8 million in capital to support ongoing development and strategic partnerships.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.
Ada Torres
Ada Torres
29 Aug 2025
DigitalX Limited posted a larger loss for FY25 despite an 18% revenue increase, driven by digital asset appreciation and a bold Bitcoin accumulation strategy.
Claire Turing
Claire Turing
29 Aug 2025
Powerhouse Ventures Limited reported a striking 348.8% jump in profit after tax to $1.82 million for FY25, driven by strategic acquisitions and a robust investment portfolio. The company’s first operating cash profit and growth in net tangible assets signal a turning point in its transformation.
Claire Turing
Claire Turing
29 Aug 2025
Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.
Ada Torres
Ada Torres
29 Aug 2025